Editorial Board — Medscape Infectious Diseases

Board Members

  • Paul G. Auwaerter, MD
    • The Johns Hopkins University School of Medicine
      Baltimore, Maryland
  • John Boyce, MD
    • Yale University School of Medicine
      Hospital of Saint Raphael
      New Haven, Connecticut
  • Matthew E. Falagas, MD, MSc, DSc
    • Alfa Institute of Biomedical Sciences
      Athens, Greece
      Tufts University School of Medicine
      Boston, Massachusetts
  • William R. Jarvis, MD
    • Jason and Jarvis Associates, L.L.C.
      Port Orford, Oregon
      National Nosocomial Infections Surveillance (NNIS) System
      US Centers for Disease Control and Prevention (CDC)
      Atlanta, Georgia
 

Board Member Details

Paul G. Auwaerter, MD
Paul G. Auwaerter, MD

Clinical Director, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Disclosure: Paul G. Auwaerter, MD, has disclosed the following relevant financial relationships:
Served as director for: Infectious Diseases Society of America (IDSA)
Served as a member of: The Anti-infective Panel, US Food and Drug Administration (FDA)

[ Back to Top ]
John Boyce, MD
John Boyce, MD

Clinical Professor of Medicine, Yale University School of Medicine; Chief, Infectious Diseases Section, Department of Medicine, Hospital of Saint Raphael, New Haven, Connecticut

Disclosure: John Boyce, MD, has disclosed the following financial relationships: Received grants for clinical research from: 3M Pharmaceuticals; Ekahau; GOJO Industries, Inc.; The Clorox Company
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: 3M Pharmaceuticals; BIOQUELL PLC; Cardinal Health; GOJO Industries, Inc.; Saraya; The Clorox Company
Received honoraria from: Advanced Sterilization Products Received income in an amount equal to or greater than $250 from: 3M Pharmaceuticals; Advanced Sterilization Products; BIOQUELL PLC; Cardinal Health; GOJO Industries; The Clorox Company

[ Back to Top ]
Matthew E. Falagas, MD, MSc, DSc
Matthew E. Falagas, MD, MSc, DSc

Director, Alfa Institute of Biomedical Sciences, Athens, Greece; Adjunct Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts

Disclosure: Matthew E. Falagas, MD, MSc, DSc, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Astellas Pharma, Inc.; Rokitan GmbH
Served as an advisor for: Bayer HealthCare Pharmaceuticals; Pfizer Inc
Served as a speaker or member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Cipla Ltd.; Merck &Co., Inc.; Novartis Pharmaceuticals Corporation; Wyeth Pharmaceuticals Inc.

[ Back to Top ]
William R. Jarvis, MD
William R. Jarvis, MD

President, Jason and Jarvis Associates, L.L.C., Port Orford, Oregon; former Chief, Investigation and Prevention Branch; Assistant Chief, National Nosocomial Infections Surveillance (NNIS) System; Chief, Epidemiology Branch; Acting Director, Hospital Infections Program; Assistant Director for Program Development, Division of Healthcare Quality Promotion; Director, Office of Extramural Research, National Center for Infectious Diseases, US Centers for Disease Control and Prevention (CDC), Atlanta, Georgia

Disclosure: William R. Jarvis, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Association for Professionals in Infection Control and Epidemiology, Inc. Served as a speaker or a member of a speakers bureau for: Becton, Dickinson and Company; C.R. Bard, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Becton, Dickinson and Company; C.R. Bard, Inc.; Excelsior Solutions, LLC; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Received income in an amount equal to or greater than $250 from: Becton, Dickinson and Company; C.R. Bard, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

[ Back to Top ]
Salim S. Abdool Karim, MBChB, PhD
Salim S. Abdool Karim, MBChB, PhD

Pro Vice Chancellor of Research, University of KwaZulu-Natal, Nelson Mandela School of Medicine, Durban, South Africa

Disclosure: Salim S. Abdool Karim, MBChB, PhD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: Merck &Co., Inc.
Applied for patent with: Gilead Sciences, Inc.

[ Back to Top ]
David W. Kimberlin, MD
David W. Kimberlin, MD

Professor of Pediatrics; Co-Director, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama

Disclosure: David W. Kimberlin, MD, has disclosed no relevant financial relationships.

[ Back to Top ]
Loren G. Miller, MD, MPH
Loren G. Miller, MD, MPH

Associate Professor of Medicine; Director, Infection Care Program, Department of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California

Disclosure: Loren G. Miller, MD, MPH, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Cubist Pharmaceuticals; GlaxoSmithKline; Pfizer Inc
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: GlaxoSmithKline; Pfizer Inc

[ Back to Top ]
Paul A. Offit, MD
Paul A. Offit, MD

Professor, Department of Pediatrics, University of Pennsylvania School of Medicine; Chief, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Disclosure: Paul A. Offit, MD, is the co-inventor of the RotaTeq® vaccine, but he receives no financial remuneration for sales of the vaccine from either the manufacturer or his employing institution."

[ Back to Top ]
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.